Article

Mortality trends in men and women with diabetes, 1971 to 2000.

National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30341-3727, USA.
Annals of internal medicine (Impact Factor: 16.1). 09/2007; 147(3):149-55.
Source: PubMed

ABSTRACT Whether mortality rates among diabetic adults or excess mortality associated with diabetes in the United States has declined in recent decades is not known.
To examine whether all-cause and cardiovascular disease mortality rates have declined among the U.S. population with and without self-reported diabetes.
Comparison of 3 consecutive, nationally representative cohorts.
Population-based health surveys (National Health and Nutrition Examination Surveys I, II, and III) with mortality follow-up assessment.
Survey participants age 35 to 74 years with and without diabetes.
Diabetes was determined by self-report for each survey (1971-1975, 1976-1980, and 1988-1994), and mortality rates were determined through 1986, 1992, and 2000 for the 3 surveys, respectively.
Among diabetic men, the all-cause mortality rate decreased by 18.2 annual deaths per 1000 persons (from 42.6 to 24.4 annual deaths per 1000 persons; P = 0.03) between 1971 to 1986 and 1988 to 2000, accompanying decreases in the nondiabetic population. Trends for cardiovascular disease mortality paralleled those of all-cause mortality, with 26.4 annual deaths per 1000 persons in 1971 to 1986 and 12.8 annual deaths per 1000 persons in 1988 to 2000 (P = 0.06). Among women with diabetes, however, neither all-cause nor cardiovascular disease mortality declined between 1971 to 1986 and 1988 to 2000, and the all-cause mortality rate difference between diabetic and nondiabetic women more than doubled (from a difference of 8.3 to 18.2 annual deaths per 1000 persons). The difference in all-cause mortality rates by sex among people with diabetes in 1971 to 1986 were essentially eliminated in 1988 to 2000.
Diabetes was assessed by self-report, and statistical power to examine the factors explaining mortality trends was limited.
Progress in reducing mortality rates among persons with diabetes has been limited to men. Diabetes continues to greatly increase the risk for death, particularly among women.

3 Followers
 · 
105 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The objective of this cross-sectional study was to assess differences in the control and treatment of modifiable cardiovascular risk factors (CVRF: HbA1c, blood pressure [BP], LDL-cholesterol, body mass index, and smoking habit) according to gender and the presence of cardiovascular disease (CVD) in patients with type 2 diabetesmellitus (T2DM) in Catalonia, Spain. The study included available data from electronic medical records for a total of 286,791 patients. After controlling for sex, age, diabetes duration, and treatment received, both men and women with prior CVD had worse cardiometabolic control than patients without previous CVD; women with prior CVD had worse overall control of CVRFs than men except for smoking; and women without prior CVD were only better than men at controlling smoking and BP, with no significant differences in glycemic control. Finally, although the proportion of women treated with lipid-lowering medications was similar to (with prior CVD) or even higher (without CVD) than men, LDL-cholesterol levels were remarkably uncontrolled in both women with and women without CVD. The results stress the need to implement measures to better prevent and treat CVRF in the subgroup of diabetic women, specifically with more intensive statin treatment in those with CVD.
    International Journal of Endocrinology 09/2014; DOI:10.1155/2014/131709 · 1.52 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: La ciencia médica no ha tenido en cuenta hasta finales del siglo XX que existen diferencias en el modo de enfermar y en el tipo de enfermedades más frecuentes entre mujeres y hombres. Existen sesgos de género en la escasa valoración de las diferencias tanto biológicas, como psicológicas y sociales. Nuestro grupo ha definido el término “morbilidad femenina diferencial” para describir y visibilizar estas diferencias. Los factores de riesgo diferenciales destacables para la mortalidad prematura diferencial son los problemas cardiovasculares, el cáncer de mama y el de colon. En cuanto a la morbilidad, la menstruación y sus trastornos es el primer factor diferencial por edad, y las enfermedades endocrinas y el dolor osteomuscular los que causan los problemas más prevalentes. También son importantes la deficiencia de hierro y las carencias de vitamina D.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Cardiovascular disease is the leading cause of death among women. Its impact on health is not only related to mortality rate because there are a number of women surviving from this disease due to scientific and technical advances in diagnostic procedures and treatment leading to a higher life expectative and high health costs. For this reason is important to implement prevention strategies for diagnosis and treatment of the main cardio- vascular risk factors. It is well known that cardiovascular disease has gender differences in presentation, evolution and prognosis that justified the formulation of specific guidelines for women by the American Heart Association which will make easier the early identification and stratification of women at cardiovascular risk according to the main risk factors and the implementation of specific therapeutic intervention. This review will be focus on the main cardiovascular risk factors in post menopausal women and will describe the charac- teristics findings of coronary heart disease in women and, the prevention strategies of cardiovascular disease.
    06/2009; 7(2).

Preview

Download
1 Download
Available from